Breast cancerMACA CANCER INFORMATION GUIDE
Understanding breast cancer.
What breast cancer is, the changes to look out for, how it is diagnosed and staged, and the treatments your care team may discuss with you.
What is breast cancer?
Breast cancer begins when cells in the breast grow out of control and form a tumour. It can grow into the surrounding breast tissue and spread to the lymph nodes under the arm and to other parts of the body.
How the breast is made up
The breast is made up of lobules, small glands that make milk, and ducts, thin tubes that carry milk to the nipple. Fatty and fibrous tissue fills the space between them and gives the breast its shape. Lymph vessels drain the breast to lymph nodes, mainly in the armpit. Most breast cancers start in the ducts; some start in the lobules.
How common is breast cancer?
Breast cancer is the most common cancer in women in most countries of the world. The World Health Organization estimates that 2.4 million women were diagnosed with breast cancer in 2024 and 694,000 died from it.
Breast cancer in men
Men can get breast cancer too, although it is rare: about 0.5–1% of breast cancers occur in men. The most common sign is a painless lump under or near the nipple. Because many men do not know they can get breast cancer, it is often found later, so any breast change in a man should also be checked.
Signs and symptoms
Breast cancer often causes no pain at first. Changes to look out for include:
- A lump or thickening in the breast or armpit, which is often painless
- A change in the size, shape or appearance of a breast
- Dimpling, redness, pitting or other changes to the skin, sometimes looking like the skin of an orange
- A change in the nipple or the skin around it (the areola), such as a nipple that turns inwards
- Unusual or bloody fluid coming from the nipple
Most breast lumps are not cancer, but every new lump or change should be checked by a health worker, even if it does not hurt.
Risk factors
Being female and getting older are the strongest risk factors. Many women who develop breast cancer have no other risk factor. Things that increase the risk include:
- Age: most breast cancers are diagnosed in women over 40.
- Family history: having close relatives who have had breast or ovarian cancer.
- Inherited gene changes: such as changes in the BRCA1, BRCA2 and PALB2 genes, which greatly increase the risk.
- Reproductive history: starting periods at a young age, having a first pregnancy later in life or never having children.
- Obesity: especially after the menopause.
- Alcohol and tobacco: drinking alcohol and smoking both increase the risk.
- Hormone therapy after the menopause: some types of hormone replacement therapy increase the risk.
- Radiation: previous radiotherapy to the chest.
Early detection
Breast cancer that is found early, when it is small and has not spread, is easier to treat successfully. There are two parts to early detection.
Knowing your breasts
Get to know how your breasts normally look and feel, so that you notice any change. Look at and feel your breasts and armpits from time to time, and see a health worker promptly about anything new.
Clinical breast examination
A trained health worker can examine your breasts to check for lumps or other changes. This can be part of a routine health check.
Screening
Screening looks for breast cancer in women who have no symptoms. Mammography, a low-dose X-ray of the breast, is usually offered to women aged 50 to 69. Women at higher risk, for example because of a strong family history or an inherited gene change, may be advised to start earlier or have other tests.
Types of breast cancer
By where the cancer starts
- Ductal carcinoma in situ (DCIS): abnormal cells are inside the ducts but have not spread into the surrounding breast tissue. It is not invasive, but it is treated to stop it becoming invasive.
- Invasive ductal carcinoma: starts in the ducts and grows into the surrounding tissue. It is the most common type of breast cancer.
- Invasive lobular carcinoma: starts in the lobules and grows into the surrounding tissue.
- Inflammatory breast cancer: a rare, fast-growing type in which cancer cells block lymph vessels in the skin, so the breast looks red, swollen and warm.
- Paget disease of the breast: a rare cancer that starts in the nipple and areola.
By what the cancer cells carry
Tests on the cancer cells show which receptors they have. This is one of the most important things for choosing treatment.
- Hormone receptor-positive: the cells have receptors for oestrogen (ER-positive) or progesterone (PR-positive), so the hormones help the cancer grow. This is the most common type.
- HER2-positive: the cells have too much of a protein called HER2, which helps them grow and divide faster.
- Triple-negative: the cells have no oestrogen, progesterone or HER2 receptors. It tends to grow faster and is more common in younger women, women of African ancestry and women with a BRCA1 gene change.
Diagnosis
If you have a breast change, your doctor will ask about your health and family history and examine your breasts and armpits. They may then arrange the following tests.
Imaging tests
- Diagnostic mammogram: an X-ray of the breast, often taking detailed images from different angles.
- Breast ultrasound: uses sound waves to show whether a lump is solid or filled with fluid. It is often used for younger women, whose breast tissue is denser.
- Breast MRI: gives detailed images and is used in some situations, such as for women at high risk.
Biopsy
A biopsy is the only sure way to diagnose breast cancer. A sample of cells or tissue is taken and examined under a microscope.
- Fine-needle aspiration: a thin needle removes cells or fluid.
- Core needle biopsy: a wider needle removes small cores of tissue. It is the most common type and is often guided by ultrasound or mammography.
- Surgical biopsy: part or all of the lump is removed in a small operation.
Tests on the cancer cells
The pathology report describes where the cancer started, how abnormal the cells look (the grade, from 1 to 3) and whether it is invasive. Every breast cancer should be tested for oestrogen and progesterone receptors and for HER2. Some early cancers also have genomic tests, which help show whether chemotherapy is likely to help.
Checking for spread
A sentinel lymph node biopsy finds and removes the first lymph nodes the cancer is likely to reach, to check them for cancer. CT, bone or PET-CT scans may be used to check whether the cancer has spread further.
Stages and outlook
The stage describes how much the cancer has grown and spread. It combines the size of the tumour, spread to lymph nodes and to other parts of the body (TNM), the grade of the cells and their receptor status.
- Stage 0: non-invasive cancer, such as DCIS, that has not spread beyond where it formed.
- Stage I: the cancer is small and in the breast, and may have reached nearby lymph nodes in tiny amounts.
- Stage II: the cancer is in the breast, nearby lymph nodes or both, and is larger or has reached more nodes than stage I.
- Stage III: the cancer has spread to several lymph nodes near the breast, or into the skin of the breast or the chest wall.
- Stage IV: the cancer has spread to other parts of the body, such as the bones, liver or lungs (metastatic breast cancer).
Outlook
Breast cancer is one of the most treatable cancers when it is found early and treatment is completed. Survival depends greatly on access to diagnosis and care: across the world, about 78% of women diagnosed with breast cancer are alive five years later, but this ranges from about 87% in high-income countries to about 42% in low-income countries. Earlier diagnosis and completing the full course of treatment are the most important ways to close that gap.
Treatment
Treatment depends on the type and stage of the cancer, its receptor status, your age and general health, and your own preferences. A team that may include surgeons, oncologists, radiologists, pathologists and nurses plans it with you. Most people have more than one type of treatment.
Surgery
- Breast-conserving surgery (lumpectomy): removes the cancer and a margin of healthy tissue around it, keeping most of the breast. It is usually followed by radiotherapy.
- Mastectomy: removes the whole breast. Breast reconstruction may be possible at the same time or later.
- Lymph node surgery: a sentinel lymph node biopsy removes only the first few nodes and causes fewer problems than removing many nodes from the armpit.
Radiotherapy
Radiotherapy uses high-energy rays to destroy any cancer cells left after surgery, lowering the chance of the cancer coming back in the breast or nearby.
Chemotherapy
Chemotherapy uses medicines to kill cancer cells throughout the body. It may be given before surgery to shrink the tumour, or after surgery to lower the risk of the cancer coming back. It is used more often for hormone receptor-negative, HER2-positive and triple-negative cancers.
Hormone therapy
For hormone receptor-positive cancers, medicines such as tamoxifen or aromatase inhibitors block the effect of oestrogen or lower its level. They are usually taken as tablets for five to ten years and reduce the risk of the cancer coming back by nearly half.
Targeted therapy and immunotherapy
HER2-positive cancers are treated with medicines that target the HER2 protein, such as trastuzumab. Some triple-negative cancers are treated with immunotherapy, which helps the immune system attack the cancer.
Clinical trials
Clinical trials are research studies that test whether a new treatment, a new combination of treatments or a new way of giving an existing treatment works better than current care. Many of today’s standard treatments were first offered through clinical trials.
What taking part involves
- Every trial has eligibility criteria, such as the type and stage of cancer, previous treatment and general health.
- Trials must be approved by a research ethics committee and, for medicines, by the national regulator. In Nigeria this includes NAFDAC and a recognised health research ethics committee.
- You will be given written information and asked for your informed consent before you join. You can ask questions at any time.
- Taking part is voluntary. You can leave a trial at any point and still receive standard care.
Finding a trial
Your treating team is the best place to start, because they know your diagnosis and which trials could suit you. Trial registries list studies that are recruiting:
- Pan African Clinical Trials Registry (PACTR): trials taking place in African countries.
- WHO International Clinical Trials Registry Platform: one search across registries worldwide.
- ClinicalTrials.gov: a large international registry run by the US National Library of Medicine.
Living with and after treatment
Side effects
Side effects depend on the treatment and usually improve once it ends. They may include:
- Tiredness, hair loss, nausea and a higher risk of infection during chemotherapy
- Sore or darkened skin in the treated area during radiotherapy
- Swelling of the arm or hand (lymphoedema) after lymph node surgery or radiotherapy
- Hot flushes, joint pain or other menopause-like symptoms with hormone therapy
- Changes to fertility. If you may want children in the future, ask about this before treatment starts
Follow-up
After treatment you will have regular check-ups and mammograms. Report any new lump, pain, swelling or other change in between appointments.
Emotional support
A breast cancer diagnosis can affect body image, relationships, work and finances. Talking with family, friends, your care team and other survivors can help. Kosi and Elizabeth have shared their own journeys through diagnosis, treatment and into patient advocacy.
Questions to ask your care team
- What type of breast cancer do I have, and what stage is it?
- What are my hormone receptor and HER2 results?
- Can I have breast-conserving surgery, or do I need a mastectomy? Is reconstruction possible?
- What are my treatment options, and what is the aim of each one?
- How might treatment affect my fertility?
- What side effects should I expect, and who do I contact if I have them?
- Is there a clinical trial that could be right for me?
